Accessibility Menu

Shandong Xinhua Pharmaceutical(FRA) XIN

Market Cap€414.53MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPON/A
5 YearN/A
1 YearN/A
1 MonthN/A
€0.59
-0.84%
-0.00Today

Shandong Xinhua Pharmaceutical Financials at a Glance

Market Cap

€414.53MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

€1.04K

Net Income (TTM)

€27.50

EPS (TTM)

€0.04

P/E Ratio

15.54

Dividend

€0.02

Beta (Volatility)

0.08 (Low)

Price

€0.59

Volume

0

Open

€0.59

Previous Close

€0.59

Daily Range

€0.59 - €0.59

52-Week Range

€0.57 - €0.87

Estimated Earnings Date

N/A

XIN News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Shandong Xinhua Pharmaceutical

Shandong Xinhua Pharmaceutical Co., Ltd. engages in the development, production and sales of pharmaceutical and synthetic chemical products. It operates the business through the following segments: Bulk Pharmaceuticals, Preparations, Chemical and Other Products. The firm's products include analgin, caffeine, amidopyrine, ibuprofen, theophylline, aspirin, hydrocortisone and pipemidic acid. The company also sells pharmaceutical raw materials, preprations, antibiotic preparations, herbal medicine, biological products, medical appliances, chinese medicines and beauty products. Shandong Xinhua Pharmaceutical was founded in 1943 and is headquartered in Zibo, China.

Industry

Pharmaceuticals

Sector

Health Care

Employees

7,240

CEO

Wen Hui Xu

Website

www.xhzy.com

XIN Financials

Key Financial Metrics (TTM)

Gross Margin

N/A

Operating Margin

N/A

Net Income Margin

N/A

Return on Equity

4.12%

Return on Capital

N/A

Return on Assets

N/A

Earnings Yield

6.44%

Dividend Yield

3.23%

Payout Ratio

N/A

Stock Overview

Market Cap

€414.53MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

696.68M

Volume

0

Avg. Volume

13.03

Financials (TTM)

Gross Profit

N/A

Operating Income

N/A

EBITDA

N/A

Operating Cash Flow

N/A

Capital Expenditure

N/A

Free Cash Flow

N/A

Cash & ST Invst.

N/A

Total Debt

N/A

Shandong Xinhua Pharmaceutical Performance Analysis

Shandong Xinhua Pharmaceutical annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20222022-12-31EUR 1,050,970,58722.6%
20232023-12-31EUR 1,045,554,378-0.5%
20242024-12-31EUR 1,087,501,6484.0%
20252025-12-31EUR 1,075,525,927-1.1%
Shandong Xinhua Pharmaceutical annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20222022-12-31EUR 0.0917.3%
20232023-12-31EUR 0.099.0%
20242024-12-31EUR 0.09-7.0%
20252025-12-31EUR 0.05-40.8%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q2 2026YOY CHG

Revenue

€244.42

+0.9%

Gross Profit

€44.43

+0.8%

Gross Margin

18.18%

+0.9%

Market Cap

€414.53MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

€0.06

N/A

Employees

7,240

N/A

Net Income

€8.17

+0.6%

EBITDA

€26.55

+0.9%

Quarterly Fundamentals

Name
Q2 2026YOY CHG

Total Cash

€447.01

+14.7%

Total Debt

€252.25

+1.1%

Accounts Receivable

€166.83

+1.0%

Inventory

€167.06

+1.1%

Long Term Debt

€80.90

+1.4%

Short Term Debt

€171.34

+0.9%

Return on Assets

2.33%

+0.5%

Return on Invested Capital

7.82%

+0.9%

Free Cash Flow

€33.05

+1.3%

Operating Cash Flow

€34.68

+1.3%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
^GSPCS&P 500
$7,684.24-0.00%
^DJIDJI
$53,254.61-0.01%
^IXICNASDAQ
$26,319.55-0.00%
BTCBitcoin
$78,890.00-0.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
PCGPG&E
$13.27-0.20%
NVDANvidia
$220.78+0.01%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x ETF
$9.97+0.11%
CNHCNH Industrial
$11.83+0.01%

Questions About XIN

What is the current price of Shandong Xinhua Pharmaceutical?

Shandong Xinhua Pharmaceutical is trading at €0.59 per share.

What is the 52-week range for Shandong Xinhua Pharmaceutical?

Over the past 52 weeks, Shandong Xinhua Pharmaceutical has traded between €0.57 and €0.87.

How much debt does Shandong Xinhua Pharmaceutical have?

As of the most recent reporting period, Shandong Xinhua Pharmaceutical reported total debt of €252.25M.

How much cash does Shandong Xinhua Pharmaceutical have on hand?

Shandong Xinhua Pharmaceutical reported €194.76M in cash and cash equivalents in its most recent financial results.

What is Shandong Xinhua Pharmaceutical’s dividend yield?

Shandong Xinhua Pharmaceutical currently has a dividend yield of 3.23%.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services